Q3 2022

Filed Nov 14, 2022 · 10-Q · 45 days after period end · 0001213900-22-071540

Q3 2022 · 10-Q

Revenue—

Net Income

-$132.46K

N/M vs Q3 2021

EPS Diluted

-$0.02

N/M vs Q3 2021

Operating Income-$132,460N/M

Operating Cash Flowderived-$32,731N/M

Same quarter

Metric	Q3 2022	Q3 2021	Q3 2020	Q3 2019
Revenue	—	$12.16M	$10.02M	$7.76M
Net Income	-$132.46K	$541.50K	$1.03M	$475.33K
EPS Diluted	-$0.02	$0.03	$0.04	$0.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

JRSIS HEALTH CARE Corp · CIK 1597892 · Engraved from SEC EDGAR